Latest eBooks

Cell and gene therapies are continuing to gain popularity, with 15 now FDA approved and hundreds more in development. While these treatments are promising, managing safety and effectiveness in patients is complex.

High-throughput and automation go hand in hand when it comes to drug discovery. The ability to screen more and analyze faster – while maintaining high quality, accurate results – is key to progressing biopharmaceuticals from the research stages through to the clinic.

Choosing the right data system can make all the difference. If you deploy a chromatography data system (CDS) in the cloud, what does it mean for your data and what GXP regulations could impact this decision?

Over recent decades, ion chromatography has become the method of choice for ion analysis and has developed into a significant chromatographic technique within the field of separation science.

Download this compendium to discover solutions for bioanalysis of antibody drugs, peptide mapping and detection of protein aggregates.

Download this eBook to learn more about methods for evaluating the deliciousness of meat alternatives including flavor, taste and texture.

The term proteomics – used to describe the large-scale characterization of proteins – was coined in the 1990s by Mark Wilkins, who was a PhD student at the time. Download this eBook to learn more about recent developments in proteomics research.

By recreating many of the cell-cell and cell-matrix interactions found in native tissues, spheroids and organoids provide more physiologically accurate models of disease and development than traditional 2D cultures.

Download this eBook to learn how modern flow cytometers are advances enabling advances in fields such as molecular biology, immunology, environmental science and pathology.

Mycoplasma contamination of manufacturing cell cultures is rare, but presents a threat for biologics manufacturers. Traditionally, testing was done using a culture-based, 28-day mycoplasma test. More recently, PCR-based alternatives have evolved, driven by an industry move to shorten lot disposition cycles and the emergence of cell-based therapeutics that require a more rapid test.